NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT01282437,Prophylactic Cranial Irradiation (PCI) vs Observation in Stage III NSCLC,https://clinicaltrials.gov/study/NCT01282437,NVALT11,COMPLETED,"For patients with stage III non-small cell lung cancer, which is radically treated, we will investigate whether prophylactic cranial irradiation (PCI) should become standard of care to prevent brain metastases.",NO,Non Small Cell Lung Cancer (NSCLC)|Radical Treatment|Stage III Non-Small Cell Lung Cancer,RADIATION: Prophylactic Cranial Irradiation,"Proportion of patients developing symptomatic brain metastasis, 24 months after randomisation","Time to develop neurological symptoms (confirmed or unconfirmed by imaging), 24 months after randomisation|Measurement of side effects (CTCAE3.0), 24 months after randomisation|Quality of Life, Measured by QLQ-C30 and EuroQol 5D, 24 months after randomisation",,Maastricht Radiation Oncology,University Medical Center Groningen|The Netherlands Cancer Institute,ALL,"ADULT, OLDER_ADULT",PHASE3,315,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,NVALT11,2009-01,2014-09,2015-03,2011-01-25,,2015-04-10,"Maastro Clinic, Maastricht, Limburg, 6229 ET, Netherlands|The Netherlands Cancer Institute, Amsterdam, Netherlands|VU Medical Center, Amsterdam, Netherlands|RT Insitute Stedendriehoek, Deventer, Netherlands|UMCG Groningen, Groningen, Netherlands|St. Antonius Ziekenhuis, Nieuwegein, Netherlands|Dr. Bernard Verbeeten Institute, Tilburg, Netherlands|UMC Utrecht, Utrecht, Netherlands|Isala Klinieken, Zwolle, Netherlands",
